While data and cost are important elements in recognizing issues, the measure of success isn’t just about the data or the numbers; it’s about ensuring that older adults can manage and maintain their expectations about health and aging in place. The post Beyond the Numbers: Every Data Point Tells a Different Story appeared first on…
The conversation wasn’t sounding good for Kensington residents on June 20. The Philadelphia neighborhood is a critical center of the nation’s opioid crisis, and the city had decided to spend $7.5 million in opioid settlement money to improve the quality of life there. But on that day, a Pennsylvania oversight board was about to vote…
A new report by datma explores how companies can use federated data models to scale RWD. The post Federated Models Offer New Paradigm for Data Monetization in Healthcare appeared first on MedCity News.
At HLTH 2024, I had dozens of conversations with providers, investors and digital health startup executives. Here are seven refreshingly honest takes I heard from them. The post 7 Hot Takes I Heard at HLTH appeared first on MedCity News.
Sarepta’s Elevidys will remain on the market with a black box warning. But this gene therapy for Duchenne muscular dystrophy still faces commercial headwinds and analysts say the company has work to do to win over patients and investors. The post Sarepta Slashes Staff, Maps Path Forward for Gene Therapy and Narrower Pipeline appeared first…
There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are putting off mergers for the time being, though some are forming joint ventures as a defense mechanism against financial uncertainty. Many are instead shedding…
In the past few years, state and local governments across the U.S. have begun spending billions in opioid settlements paid by companies accused of fueling the overdose crisis. But where is that money going, who is getting it, and is it doing any good? KFF Health News, partnering with the Johns Hopkins Bloomberg School of…
Capricor Therapeutics said the FDA asked for more data supporting the efficacy of Deramiocel, the biotech’s off-the-shelf cell therapy for treating the heart complications of Duchenne muscular dystrophy. Those data could come from an ongoing Phase 3 study expected to yield preliminary data soon. The post FDA Turns Down Capricor Cell Therapy for Cardio Complications…
By EMMANUEL ANIMASHAUN The Centers for Medicare & Medicaid Services (CMS) Star Ratings system represents a cornerstone of quality assessment in Medicare Advantage (MA), designed to empower consumers with transparent information while rewarding plans that deliver superior care. Yet recent developments, particularly the seismic downgrading of Humana’s ratings reveal an unintended consequence: a system created…
Maddy Olcott planea iniciar su carrera profesional después de graduarse. Pero esta estudiante de tercer año en la Universidad Estatal de Nueva York, campus Purchase, no tiene planes, por ahora, de formar una familia. Ni siquiera con los incentivos que ofrece el gobierno de Donald Trump como los “bonos por bebé” de $1.000 o los…